Oxygen test could boost cervical cancer survival
NCT ID NCT05029258
First seen May 18, 2026 · Last updated May 20, 2026 · Updated 1 time
Summary
This study aims to find better ways to measure oxygen levels in cervical cancer tumors. Low oxygen (hypoxia) makes tumors harder to treat with radiation. Researchers will use MRI scans and genetic tests on 30 patients to see which markers best identify hypoxic tumors. The goal is to help doctors choose the right patients for oxygen-modifying therapies in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Christie NHS Foundation Trust
Manchester, Greater Manchester, M20 4BX, United Kingdom
Conditions
Explore the condition pages connected to this study.